Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

Alpha Generation from the New Entries in the 'KOSDAQ Rising Stars' for 2025

Douglas Research Advisory

Equity Bottom-Up

<ul>
<li>T&amp;L's key investment highlights include its exceptional sales growth led by its core wound dressing/cosmetic product Mighty Patch.</li>
<li>It had a CAGR sales growth of 44% from 2020 to 2024. Its operating profit increased at even faster rate (CAGR of 56% from 2020 to 2024. </li>
<li>Considering T&amp;L's 40%+ per year sales growth and 50%+ per year operating profit growth from 2020 to 2024 combined with 30%+ ROE, the company is deeply undervalued. </li>
</ul>


T&amp;L's key investment highlights include its exceptional sales growth led by its core wound dressing/cosmetic product Mighty Patch.
It had a CAGR sales growth of 44% from 2020 to 2024. Its operating profit increased at even faster rate (CAGR of 56% from 2020 to 2024. 
Considering T&amp;L's 40%+ per year sales growth and 50%+ per year operating profit growth from 2020 to 2024 combined with 30%+ ROE, the company is deeply undervalued. 


T&L Co Ltd

Korea Small Cap Gem #42: T&L Co